Extracellular Vesicles (EVs) derived from different cell types by ectocytosis (microvesicles) or endocytosis (exosomes) may serve as intercellular messengers in pathogenic processes. Circulating mitochondrial DNAs (mtDNA) are potent danger-associated molecular patterns (DAMPs) found in inflammatory diseases including viral infections. We evaluate the EVs profile and plasma mtDNA levels in a well-characterized cohort of HIV-infected patients and controls.
Plasma samples from HIV-infected patients from the HIV Biobank-Spanish HIV/AIDS Network and 2 hospitals in Galicia were selected. Five groups were defined: 1) treatment-ART; 2) receiving ART with non-detectable viremia (ND) > 1 year); 3) elite controllers (EC) (<50 copies/mL without ART > 1 year); 4) viremic controllers-VC (HIV-RNA >50 and < 2000 copies/mL without ART for more than 1 year); and 5) a control group of HIV negatives. EVs (<1μm, CD9+) were quantified and characterized by flow cytometry using monoclonal antibodies targeting their source CD61/CD41 for platelets; CD16/CD11b for neutrophils. MitoTrackerDeepRed identified EVs containing mitochondria. mtDNA was quantified using a quantitative real-time PCR assay.
120 HIV-infected patients (30 naïve, 30 ND, 30 EC, and 30 VC) and 30 controls were included. The table shows the main characteristics of the study population and results. EVs numbers were expanded at least 10 fold in all HIV-infected groups compared to controls’ counts. Most EV had platelet markers (>79%) within the HIV groups, and few had neutrophil markers (< 2%). A minority of platelet-derived EVs contained mitochondria, but most neutrophil-derived EVs did. Mitochondria+ EV were less frequent for those on ART than in other HIV+ groups. A positive correlation was found between the number of platelet-derived mitochondria+ EVs and total plasma mtDNA levels (rho=0.727; p<0.001) but not for neutrophil-derived mitochondria+ EVs. Mitochondrial density (MFI) was greater in controls’ EVs than in HIV-infected groups, lowest levels for those on ART.
A massive release of platelet-derived EVs occurs during HIV infection regardless of HIV status. EVs count correlates with plasma mtDNA levels. HIV infection and ART both appear to diminish mitochondrial density in EVs yet as EVs numbers are expanded, total mitochondrial levels in plasma are preserved in HIV infection or increased. The mechanisms underlying these perturbations in EVs levels and the mitochondria within them in HIV infection are not known.